"For many drugs, delivery is as big a challenge as development. Current Drug Delivery provides essential information for all drug scientists."
Jhon de Jersey
The Univ. of Queensland, Australia
|Forthcoming Special Issue(s)|
Biodegradable drug delivery systems for cancer therapy
Guest Editor(s): Crispin R. Dass, Pornsak Sriamornsak, Wui Tin Wong
Tentative Publication Date: September, 2015
Submit Abstract via Email Download Description
|Published Special Issue(s)|
RECENT DEVELOPMENTS IN PHARMACEUTICAL SCIENCES
Guest Editor(s): Nilufer YUKSEL, Sinem ASLAN ERDEM, Zerrin SEZGIN BAYINDIR
I would like to thank the entire editing team of the Current Drug Delivery for their commitment to resolve all issues regarding the publication of my article. All sectors work in consonance and are quite agile. |
I believe that my work is of interest both in the pharmaceutical industry and in the biotechnology industry, since once the bioavailability of the active substance is guaranteed at its site of action, the better is the result for the patient. And so it is in the interest of the whole chain of health goods production, to encourage them to study this issue of biopharmaceutical stability in depth.
At the moment I am working with ophthalmic release systems, which is still in progress. I look forward to future contributions to your journal.
Aline Gravinez Perissinato
(LACFAR, Institute of Chemistry, Federal University of Alfenas, Alfenas, Brazil)
Hesperetin Liposomes for Cancer Therapy
, 2016; 13
Joy Wolfram, Bronwyn Scott, Kathryn Boom, Jianliang Shen, Carlotta Borsoi, Krishna Suri, Rossella Grande, Massimo Fresta, Christian Celia, Yuliang Zhao, Haifa Shen and Mauro Ferrari
Abstract PubMed Reprints Eprints Permissions